aTyr Pharma Ord Shs
LIFE10.130USD
+0.030+0.30%
終値 03/27, 16:00（ET）15分遅れの株価
633.72M時価総額
8.91直近12ヶ月PER
詳細情報 aTyr Pharma Ord Shs 企業名
Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.
aTyr Pharma Ord Shsの企業情報
企業コードLIFE
会社名Ethos Technologies Inc
上場日May 07, 2015
最高経営責任者「CEO」Colis (Peter George)
従業員数- -
証券種類Ordinary Share
決算期末May 07
本社所在地1606 Headway Circle
都市AUSTIN
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号78754
電話番号13026365400
ウェブサイトhttps://www.ethos.com/
企業コードLIFE
上場日May 07, 2015
最高経営責任者「CEO」Colis (Peter George)
aTyr Pharma Ord Shsの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
Dr. Paul R. Schimmel, Ph.D.
Dr. Paul R. Schimmel, Ph.D.
Independent Director
Independent Director
--
--
Ms. Jill M. Broadfoot
Ms. Jill M. Broadfoot
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nancy E. Denyes, J.D.
Ms. Nancy E. Denyes, J.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Dr. Sara A. Zaknoen, M.D.
Dr. Sara A. Zaknoen, M.D.
Independent Director
Independent Director
--
--
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
--
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
Dr. Paul R. Schimmel, Ph.D.
Dr. Paul R. Schimmel, Ph.D.
Independent Director
Independent Director
--
--
Ms. Jill M. Broadfoot
Ms. Jill M. Broadfoot
Chief Financial Officer
Chief Financial Officer
--
--
収益内訳
会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Fri, Feb 20
更新時刻: Fri, Feb 20
株主統計
種類
株主統計
株主統計
比率
Fidelity Management & Research Company LLC
15.00%
Federated Hermes Global Investment Management Corp.
10.76%
BlackRock Institutional Trust Company, N.A.
6.10%
The Vanguard Group, Inc.
5.06%
State Street Investment Management (US)
4.28%
他の
58.79%
株主統計
株主統計
比率
Fidelity Management & Research Company LLC
15.00%
Federated Hermes Global Investment Management Corp.
10.76%
BlackRock Institutional Trust Company, N.A.
6.10%
The Vanguard Group, Inc.
5.06%
State Street Investment Management (US)
4.28%
他の
58.79%
種類
株主統計
比率
Venture Capital
24.49%
Individual Investor
12.09%
Investment Advisor
10.75%
Investment Advisor/Hedge Fund
0.79%
他の
51.88%
機関投資家保有株
更新時刻: Fri, Jan 30
更新時刻: Fri, Jan 30
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q1
240
61.49M
62.75%
-12.15M
2025Q4
244
60.50M
61.75%
-16.64M
2025Q3
241
62.16M
63.44%
-11.39M
2025Q2
207
66.51M
74.72%
-166.29K
2025Q1
151
62.77M
70.80%
+2.91M
2024Q4
133
55.86M
66.65%
-3.11M
2024Q3
108
48.56M
65.39%
-7.43M
2024Q2
103
48.81M
71.98%
+527.76K
2024Q1
101
42.52M
63.83%
-4.61M
2023Q4
100
41.92M
72.67%
-1.23M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Fidelity Management & Research Company LLC
14.70M
15%
+1.35M
+10.09%
Sep 30, 2025
Federated Hermes Global Investment Management Corp.
10.54M
10.76%
-4.12M
-28.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.98M
6.1%
+635.14K
+11.89%
Sep 30, 2025
The Vanguard Group, Inc.
4.96M
5.06%
-669.06K
-11.88%
Dec 31, 2025
State Street Investment Management (US)
4.20M
4.28%
+2.96M
+238.49%
Sep 30, 2025
GSA Capital Partners LLP
706.73K
0.72%
+210.44K
+42.40%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.18M
2.22%
+80.13K
+3.82%
Sep 30, 2025
Millennium Management LLC
1.89M
1.93%
+290.72K
+18.17%
Sep 30, 2025
UBS Financial Services, Inc.
4.34M
4.43%
+2.59M
+148.61%
Sep 30, 2025
Schimmel (Paul R Ph.D.)
1.10M
1.12%
+100.00K
+9.99%
Mar 01, 2025
詳細を見る
関連ETF
更新時刻: Fri, Jan 30
更新時刻: Fri, Jan 30
銘柄名
比率
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
iShares Russell 2000 Value ETF
0%
Vanguard US Momentum Factor ETF
0%
Pacer WealthShield ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
Avantis US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
詳細を見る
iShares Micro-Cap ETF
比率0.01%
ProShares Hedge Replication ETF
比率0%
Global X Russell 2000 ETF
比率0%
Invesco Dorsey Wright SmallCap Momentum ETF
比率0%
iShares Russell 2000 Value ETF
比率0%
Vanguard US Momentum Factor ETF
比率0%
Pacer WealthShield ETF
比率0%
Direxion Daily S&P Biotech Bull 3X Shares
比率0%
Avantis US Small Cap Equity ETF
比率0%
ProShares UltraPro Russell2000
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
